During the past decade, catheter ablation of atrial fibrillation (AF) has evolved rapidly from
an investigational procedure to its current status as a commonly performed ablation …

Colchicine, a natural and ancient drug still used today, is traditionally considered the staple
therapy for gout and a second-line treatment for pericarditis, as well as a basic part of …

Background The role of circulating inflammatory factors in atrial fibrillation (AF) occurrence
and recurrence remains inconclusive. Methods We conducted a meta-analysis of …

Objectives: The purpose of the present study was to test the potential of colchicine, an agent
with potent anti-inflammatory action, to reduce atrial fibrillation (AF) recurrence after …

Background—Inflammation has been linked to the genesis of stroke in atrial fibrillation (AF)
and is implicated in early recurrent arrhythmia after AF ablation. We aimed to define the time …

Objectives: We sought to clarify the efficacy of corticosteroid therapy for preventing atrial
fibrillation (AF) recurrence after pulmonary vein isolation (PVI). Background: The …

Background—We previously demonstrated that treatment with antiarrhythmic drugs (AADs)
during the first 6 weeks after atrial fibrillation (AF) ablation reduces the incidence of clinically …

Background Our group previously showed that colchicine treatment is associated with
decreased early recurrence rate after ablation for atrial fibrillation (AF). Objective The …

The use of blanking periods, the immediate period postablation during which transient
tachyarrhythmia episodes are not considered recurrences, has been predicated on the …

Atrial fibrillation (AF) causes heart failure, ischemic strokes, and poor quality of life. The
number of patients with AF is estimated to increase to 18 million in Europe in 2050 …